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Abstract: We present the case of a 58-year-old woman with a renin secreting typical bronchopulmonary carcinoid. This patient 
showed hypotension, constipation and fatigue due to extensive hypokaliemia (K = 1.9 meq/L). Aldosterone (102.7 ng/100 mL) and 
renin (46 ng/mL) were excessively elevated at that time, but cortisol level was normal. Routine chest roentgenography and computed 
tomography revealed a nodular lesion in the upper left lung lobe, which was suspicious for a neurosecretory pulmonary tumor. The final 
diagnosis was made by using bronchoscopic procedures and the histologically diagnosis was compatible as a typical pulmonary carcinoid. 
The tumor was resected curatively, and the renin and aldosterone level became normal. A year after the patient looks healthy.
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case Report
A  58  year-old  woman  entered  our  hospital,  with 
symptoms of constipation, excessive urine secretion 
(over  2  liter/day—polyouria)  and  severe  muscle 
fatigue.  She  had  a  negative  medical  history  and 
she hadn’t used alcohol or drugs of any type. She 
complained of persistent dry cough and anorexia—
her body weight had decreased 10 kgs during the last 
two months period. On evaluation, the patient looked 
sick; she was pale, her temperature was 36.1 °C, her 
blood pressure was 100/60 mmHg, and her pulse rate 
was 70 bpm. The clinical examination revealed total 
muscle  fatigue  of  arms  and  legs,  without  specific 
neurological signs. The patient couldn’t walk or stand 
without help. She said that she had remained in bed 
during the main part of the day for the last week.
The initial laboratory data were: Hct = 31%, Hb = 10.9 
g/dL, Wbc = 20.250 k/µL; (91% were granulocytes and 
9% were lymphocytes), Platelets = 438.000/µL, Glu = 140 
mg/dL, BUN = 44 mg/dL, Creatine = 0.9 mg/dL, K = 1.9 
meq/L, Na = 140 meq/L, Ca = 9.6 mg/dL, SGOT = 11 IU/L, 
SGPT = 15 IU/L, ALP = 85 IU/L, LDH = 147 IU/L, 
CPK  =  53  IU/L,  Bill  =  0,4  mg/dL.  Her  arterial 
blood  gasses  were  pH  =  7.48,  pO2  =  73  mmHg, 
pCO2 = 44 mmHg, HCO3 = 36.5, SpO2 = 94%. All 
these demonstrated metabolic alkalosis.
The chest X-ray that was performed, demonstrated 
opacity without cavitation to the left upper lung lobe 
(Fig. 1). During next day, the patient was extremely 
tired, febrile and her breath frequency exceeded 22 
per  minute  (tachypnea).  Finally,  she  got  intubated 
because of severe respiratory (hypercapnic- elevated 
PCO2) acidosis. The measurement of 24 hour-urine 
secretion of sodium (108,2 mEq/L) and potassium 
(34,8 mEq/L), showed extensive hyperkaliurea. On 
the contrary, urine 5-HIAA was normal (5 mg; nor-
mal range: 5–100 mg). After 3 days, the patient extu-
bated,  without  respiratory  muscle  weakness,  while 
she had received intravenously high amount of solu-
tions with potassium. The patient remained with low 
serum potassium (hypokaliemia), despite the exten-
sive intravenous replacement. We measured the serum 
levels of aldosterone, aldolase, cortisone, and renin in 
order to find out a responsible specific disease for this 
condition. The laboratory data are presented in Table 
1. We considered as possible the existence of para-
neoplasmatic syndrome.
The CT scanning of the thorax revealed a lung 
nodule, at the upper anterior left lung lobe, without 
collateral  lymphadenopathy  (Fig.  2).  The  CT 
scanning of the brain, and upper and lower abdomen 
departments, were negative for any kinds of lesions 
(secondary  metastatic  sites)  and  excluded  the 
coexistence of juxtaglomerular tumors.
The  values  of  tumor  markers  were  within  nor-
mal  range.  Urine  examination  was  also  normal. 
Figure 1. Chest X-ray revealed a nodule without cavitations to the upper lung lobe of the left lung.Levels of hormones in serum
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Smear examination and sputum culture were negative 
for Mucobacterium tuberculosis and the tuberculin 
skin test was negative too.
The patient underwent a fiberoptic bronchoscopy. 
We  found  a  highly  vascular  endobronchial  mass 
with  a  reddish  smooth-looking  surface,  into  the 
right  anterior  sub  segmental  bronchus  of  the  left 
upper  lung  lobe.  The  bronchial  biopsy  revealed 
numerous membrane-bound neurosecretory granules 
characteristic of neuroendocrine tumor (pulmonary 
carcinoid tumor).
Three days later, we planned the surgical wedge 
resection of the carcinoid. The extended histopathol-
ogy study revealed the pattern of the typical carcinoid 
tumor of the lung, because of the absence of necrosis. 
(Fig. 3).
Two  weeks  after  the  surgical  procedure,  the 
patient’s blood pressure was measured and was found 
normal and the renin activity-levels serum were found 
normal, too (Table 1).
Discussion
We present, for the first time, a female patient with 
hypokalemia due to renin secretion from a bronchial 
carcinoid tumor. After surgical resection of the tumour, 
the patient became asymptomatic, and the serum renin 
level was decreased to normal values; these findings 
strongly  suggested  that  the  clinical  symptoms  and 
signs were due to tumor over-secretion of renin.
The estimated annual incidence of carcinoid tumors   
is 1–2 cases per 100,000 people.1 In fact, the overall 
incidence of carcinoid tumors seems to have sharply 
increased over the past few decades, perhaps, due to a 
more accurate diagnosis, supported by new diagnos-
tic techniques.2,3 The sex distribution of overall inci-
dence of carcinoid tumors is almost equal. However, 
in those aged ,50 years, the carcinoid incidence in 
females is almost twice than in males.3
Bronchial carcinoid tumors are considered a low-
grade  malignant  neoplasm  comprised  of  neuroen-
docrine  cells.  These  tumors  comprise  25%  of  all 
Table 1. Levels of commonest hormones which are associated with potassium homeostasis.
1st measurement 2nd measurement (after therapy) normal values
Aldosterone 102.7 ng/100 mL 5.6 ng/100 mL 0.7–15
ACTH 14 ng/100 mL 23 ng/100 mL 5–25
Cortisol 15 µg/100 mL 22.7 µg/100 mL 5–25
Renin 46 ng/mL 2.7 ng/mL 0.2–2.7
Figure 2. Thorax CT scanning revealed a left lung nodule (diameter 21 × 14 mm), at the upper anterior lung lobe without collateral lymphadenopathy.Tryfon et al
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carcinoid tumors but only 5% of all primary lung 
cancers.4,5 About 90% of the carcinoid tumors are well 
differentiated with rare mitoses, pleomorphism, and 
necrosis.6 These are referred as “typical” carcinoid 
tumors7 and the other 10% is referred as “atypical”.
Carcinoid  tumours  have  the  ability  to  secrete 
vasoactive  peptides,  which  are  initially  respon-
sible  for  clinical  presentation  and  complications. 
Carcinoids  have  been  found  to  secrete  serotonin 
(5-hydroxytryptamine;  5-HT),  bradykinins,  tachy-
kinins,  histamine,  substance  P,  adrenocorticotropic 
hormone,  prostaglandins,  kallikrein,  dopamine  and 
several other peptides, although 5-HT production is 
the most prominent.1,8 There was no data related to 
renin secretion from these tumors,9 as was in the case 
with our patient.
The  carcinoid  syndrome—a  paraneoplasmatic 
syndrome—is very rare in patients with pulmonary 
carcinoids,  occurring  in  approximately  2%  of 
cases.  Its  characteristic  symptoms  are  diarrhoea, 
flushing, palpitations and, less frequently, wheezing. 
The severity of these symptoms is related both to 
the  location  of  the  tumour  (related  to  drainage  to 
systemic circulation, especially in liver metastases) 
and  to  the  tumour  mass.2,3  The  5-HT  is  the  most 
frequently detected peptide responsible for carcinoid 
syndrome. In rare cases, carcinoid crisis is induced 
by the release of a large concentration of vasoactive 
substances into the systemic circulation, after tumour 
manipulation, induction of anaesthesia or intubation.1–3 
Contradicting  these  clinical  signs,  our  patient  had 
marked hypotension, without any hypertension crisis, 
and her serum levels of the 5-HT were in a normal 
range. Carcinoid syndrome with hypertension crisis 
due to tumor release of enormous amount of renin 
has never been described before.10,11
Another  paraneoplastic  syndrome  is  Cushing’s 
Syndrome (CS), which is present in approximately 
2%  of  patients  with  pulmonary  carcinoid.  This  is 
characterized by ectopic adrenocorticotropic hormone 
(ACTH)  production,  resulting  in  hypercortisolism. 
Ectopic ACTH production resulting in CS is seen in 
a small number of malignancies. Bronchial carcinoid 
is the most frequent cause (25%), whereas small cell 
lung cancer (11%) is the second one.12 Frequent signs 
of hypercortisolism are weakness, hypertension, glu-
cose intolerance, hypokalemia, alkalosis, weight loss, 
anemia, and hyperpigmentation. The typical features 
of CS are more frequent in slowly progressing tumors. 
Our patients had no signs of CS and her ACTH levels 
were in the normal range.
The renin-angiotensin-aldosterone axis regulates 
the molecular pathway of sodium reabsorption in the 
cortical collecting duct (CD). The CD, which is sited 
at the end of the nephron, played the critical role in the 
reabsorption of sodium via the aldosterone-activated 
Figure 3. photomicrograph shows small nests of uniform high-grade epithelial endocrine cells, without necrosis or mitosis (,2 mm2), classified as a typical 
carcinoid tumor of the lung (original magnification, ×100 and ×300; hematoxylin-eosin stain).Levels of hormones in serum
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mineralocorticoid  receptor  (MR).  Aldosterone, 
in  response  to  renin  and  angiotensin  governs  the 
overall  expression  of  critical  proteins  for  this 
purpose.  In  addition,  both  the  CD  and  the  Thick 
Ascending Limb of the Loop of Henle (TALLH) has 
the main role of potassium and protons secretion.13 
Pathophysiologically,  hypokalemia  and  metabolic 
alkalosis  can  be  noted  due  to  the  compensatory 
hyperreninemic hyperaldosteronism, as was the case 
with our patient (See Fig. 4).
The appropriate therapeutic decision for patients 
with bronchial carcinoid tumors is made on the basis of 
three components: histologic findings, clinical staging 
with bronchoscopy and computed tomography, and, in 
some instances, is based on intraoperative lymph node 
staging. Most tumors are localized and the likelihood 
of  local  recurrence  after  resection  is  small.  This 
resulted in a 5-year survival nearly 90% of patients 
with  localized  disease  and  70%  in  patients  with 
regionally advanced or metastatic disease.14–16 Limited 
resections such as wedge resection or segmentectomy 
for peripheral tumors and isolated bronchial sleeve 
resection or sleeve lobectomy for proximal tumors 
should be considered, when feasible for early stage 
typical  bronchial  carcinoid  tumors,  because  local 
recurrence is unlikely and survival is excellent.17,18 
Our patient after the wedge resection procedure was 
healthy  and  needed  no  additional  treatment. After 
one year follow up, the patient’s x-ray chest film was 
without abnormal findings, and her renin serum level 
was normal.
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Figure 4. The renin-angiotensin-aldosterone axis and molecular pathways of sodium reabsorption in the nephron. 
notes: A cartoon of a nephron is shown, with sodium-reabsorbing cells of the thick ascending limb of the loop of Henle (TALLH), distal convoluted 
tubule (DCT), and collecting duct (CD). The latter is responsible for fine regulation via the aldosterone-activated mineralocorticoid receptor (MR). In all 
cells, sodium exits the basolateral compartment via the Na/K-ATpase (not shown).19 Renin levels stimulate the the axis initiating the transformation of 
angiotensinogen to angiotensin I. Aldosterone synthesis is controlled by angiotensin II.
The figure taken and adjusted from reference 19.
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